D. E. Shaw & Co., Inc. Blueprint Medicines Corp Put Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $277,530 - $397,650	3,300 Added 31.13%	13,900 $1.29 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $281,094 - $358,974	3,300 Added 45.21%	10,600 $1.14 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $342,370 - $481,800	7,300 New	7,300 $366,000

354

60.7M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.66B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.